Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2025

Genmab — Februar 2025

Planlagt Fastgjort Låst Flyttet Genmab
699 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #138

    whatever they were on before starting this trial; it is not further specified in this data; but as Hemlibra is such a dominant player in this market, i would think your guess would be correct for most patients

    1 Reply Last reply
    0
    • A Offline
      A Offline
      Aaanditsgone
      wrote on sidst redigeret af
      #139

      Time for an upward adjustment of Mim8 peak sales estimates, perhaps?

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #140

        Er det grunden til at de først sender ansøgningen i H2 2025. Det var vist tidligere nu de skulle have sendt ansøgningen.

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #141

          At de vil have børn med i godkendelsen fra start.

          1 Reply Last reply
          0
          • troldmandenT Offline
            troldmandenT Offline
            troldmanden
            wrote on sidst redigeret af
            #142

            Hvilke peak sales estimater har i set på Mim8?

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #143

              Jeg har noteret 6,4 mia dkk i 2031. Kan ikke huske, hvor jeg har tallet fra.

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GUHO
                wrote on sidst redigeret af
                #144

                Citi har ligget højt på Mim8 på 1,9 mia. dollars mens konsensus skulle være 1,1. Samme artikel nævner 6,4 mia. dkk i 2031 som Bulder

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  GUHO
                  wrote on sidst redigeret af
                  #145

                  Page Not Found - NPinvestor x Netposten

                  favicon

                  NPinvestor x Netposten (npinvestor.dk)

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #146

                    Helimbra solgte i 2023 for 4,7 mia $. https://finance.yahoo.com/news/hemlibra-emicizumab-sales-increase-8-055300995.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAFN6KMaKixReHe__AJhRzQORzfQmBY-WjuR584ocJwn_q8Ibw3pEEAXgR9CvT0hp04-RxR8AZs3_pCGnH80yXz1CXP-Ks2q3SLlATyV70hIzx0xetat5zg_xLXwOXN7u2UvuhZERCY2AE0p2sRV99xUzMnf02tkTrXJfvRdCS7jz

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #147

                      Hemab Therapeutics Presents Interim Data from Ongoing Phase 2 Study of HMB-001 as First Ever Prophylactic Treatment in Glanzmann Thrombasthenia and Preclinical Data from HMB-002 in Von Willebrand Disease at the 2025 EAHAD Annual Congress https://hemab.com/#post-hemab-therapeutics-presents-interim-data-from-ongoing-phase-2-study-of-hmb-001-as-first-ever-prophylactic-treatment-in-glanzmann-thrombasthenia-and-preclinical-data-from-hmb-002-in-von-willebrand-dise

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        DaPhamius
                        wrote on sidst redigeret af
                        #148

                        Hvad er forventningen til regnskabet på mandag?

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gdn55
                          wrote on sidst redigeret af
                          #149

                          Mener først regnskabet kommer den 12.02, altså onsdag

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gdn55
                            wrote on sidst redigeret af
                            #150

                            den

                            1 Reply Last reply
                            0
                            • D Offline
                              D Offline
                              DaPhamius
                              wrote on sidst redigeret af
                              #151

                              Mente også onsdag. Forventer folk opdatering på JNJ og fremtidig pipeline eller rene tal som vi for det meste kender i forvejen?

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #152

                                we recently had a pipeline update, they will repeat that. they should give financial guidance for 2025

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #153

                                  Knock-Your-Socks-Off-News – February 2025 https://www.linkedin.com/pulse/knock-your-socks-off-news-february-2025-genmab-qlnee/

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Raun
                                    wrote on sidst redigeret af
                                    #154

                                    US noteringen er i gang med at finde nye bunde 😞

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #155

                                      Wolfgang Miesbach
                                      @miesbach
                                      Excellent presentation by Dr. Sivapalaratnam #EAHAD2025, prophylactic treatment results of a phase 1/2 study using bispecific antibody HMB-001 https://x.com/miesbach/status/1887942918117167354

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #156

                                        Brian O Mahony
                                        @Brianhemophilia
                                        Sivapalaratnam #EAHAD2025 on HMB-001 trial for Glanzmanns. Encouraging data with significant reduction in treated bleeds. This is a very difficult condition with ABR up to 80. New treatment options urgently required. https://x.com/Brianhemophilia/status/1888457175405572604

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #157

                                          man requiring red cell transfusions every ~10 days; could discontinue transfusions with HMB-001 after 43days

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper